Robert Olstein's HOLX Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 0 shares of Hologic, Inc. (HOLX) worth $0, representing 0.00% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Robert Olstein has maintained a strategic position in HOLX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 95,000 shares. Largest reduction occurred in Q4 2025, reducing 113,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Hologic (HOLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hologic (HOLX) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2016 | +187,000 | New Buy | 187,000 | $34.60 |
| Q4 2016 | -3,000 | Reduce 1.60% | 184,000 | $40.12 |
| Q1 2017 | -17,000 | Reduce 9.24% | 167,000 | $42.55 |
| Q2 2017 | -75,500 | Reduce 45.21% | 91,500 | $45.38 |
| Q3 2017 | +28,200 | Add 30.82% | 119,700 | $36.69 |
| Q4 2017 | +28,000 | Add 23.39% | 147,700 | $42.75 |
| Q1 2018 | +20,000 | Add 13.54% | 167,700 | $37.36 |
| Q2 2018 | -39,700 | Reduce 23.67% | 128,000 | $39.75 |
| Q3 2018 | -6,100 | Reduce 4.77% | 121,900 | $40.98 |
| Q4 2018 | -53,900 | Reduce 44.22% | 68,000 | $41.10 |
| Q1 2019 | -7,000 | Reduce 10.29% | 61,000 | $48.39 |
| Q2 2019 | -5,500 | Reduce 9.02% | 55,500 | $48.02 |
| Q3 2019 | -55,500 | Sold Out | 0 | $0.00 |
| Q1 2020 | +90,000 | New Buy | 90,000 | $35.10 |
| Q2 2020 | -65,000 | Reduce 72.22% | 25,000 | $57.00 |
| Q3 2020 | -25,000 | Sold Out | 0 | $0.00 |
| Q2 2021 | +95,000 | New Buy | 95,000 | $66.72 |
| Q3 2021 | -19,190 | Reduce 20.20% | 75,810 | $73.82 |
| Q4 2021 | +9,190 | Add 12.12% | 85,000 | $76.56 |
| Q1 2022 | +24,000 | Add 28.24% | 109,000 | $76.82 |
| Q2 2022 | -17,000 | Reduce 15.60% | 92,000 | $69.30 |
| Q4 2022 | -17,000 | Reduce 18.48% | 75,000 | $74.81 |
| Q1 2023 | -19,000 | Reduce 25.33% | 56,000 | $80.70 |
| Q2 2023 | -3,000 | Reduce 5.36% | 53,000 | $80.96 |
| Q3 2023 | +37,000 | Add 69.81% | 90,000 | $69.40 |
| Q4 2023 | +2,000 | Add 2.22% | 92,000 | $71.45 |
| Q3 2024 | -7,000 | Reduce 7.61% | 85,000 | $81.46 |
| Q4 2024 | +5,000 | Add 5.88% | 90,000 | $72.09 |
| Q1 2025 | +25,000 | Add 27.78% | 115,000 | $61.77 |
| Q3 2025 | -2,000 | Reduce 1.74% | 113,000 | $67.49 |
| Q4 2025 | -113,000 | Sold Out | 0 | $0.00 |
Robert Olstein's Hologic Investment FAQs
Robert Olstein first purchased Hologic, Inc. (HOLX) in Q2 2016, acquiring 187,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Hologic, Inc. (HOLX) for 36 quarters since Q2 2016.
Robert Olstein's largest addition to Hologic, Inc. (HOLX) was in Q2 2016, adding 187,000 shares worth $6.47 M.
According to the latest 13F filing for Q4 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 0 shares of Hologic, Inc. (HOLX), valued at approximately $0.
As of the Q4 2025 filing, Hologic, Inc. (HOLX) represents approximately 0.00% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in Hologic, Inc. (HOLX) was 187,000 shares, as reported at the end of Q2 2016.